发明授权
- 专利标题: Processes and intermediates for preparing fused heterocyclic kinase inhibitors
- 专利标题(中): 制备融合杂环激酶抑制剂的方法和中间体
-
申请号: US12231297申请日: 2008-08-29
-
公开(公告)号: US08907091B2公开(公告)日: 2014-12-09
- 发明人: Franck Raeppel , Ljubomir Isakovic , Stephen William Claridge , Michael Mannion , Lijie Zhan , Marie-Claude Granger , Arkadii Vaisburg , Miguel Nantel
- 申请人: Franck Raeppel , Ljubomir Isakovic , Stephen William Claridge , Michael Mannion , Lijie Zhan , Marie-Claude Granger , Arkadii Vaisburg , Miguel Nantel
- 申请人地址: CA Montreal
- 专利权人: Methylgene Inc.
- 当前专利权人: Methylgene Inc.
- 当前专利权人地址: CA Montreal
- 代理机构: Wood, Phillips, Katz, Clark & Mortimer
- 主分类号: C07D513/04
- IPC分类号: C07D513/04 ; C07D213/51 ; C07D495/04 ; C07D213/61 ; C07D213/38
摘要:
This invention relates to processes and intermediates for manufacturing fused heterocyclic-type kinase inhibitor compounds, such as thienopyridine-based compounds, and to processes and intermediates for preparing intermediates that are useful in the manufacture of fused heterocyclic-type kinase inhibitor compounds, such as thienopyridine-based compounds, particularly at an industrial level.
公开/授权文献
信息查询